发明名称 METHOD FOR OPTIMIZING BLOOD UTILIZATION
摘要 A method for measuring the utilization of blood products including receiving blood product utilization data from a group of patients of a health care facility having related diagnoses over a specified period of time, executing a blood management software program to determine a patient population that received a blood product at the health care facility during the specified period of time, the patient population being identified from a group of patients having related diagnoses, generating a transfusion exposure score, analyzing a plurality of transfusion exposure scores, and transforming a transfusion exposure score from one of the plurality of identified patient populations into a transfusion propensity index score, the transfusion propensity index score being representative of a clinical opportunity to improve the utilization of blood products at the health care facility for which the transfusion exposure score of the identified patient population was calculated.
申请公布号 US2016005139(A1) 申请公布日期 2016.01.07
申请号 US201514853038 申请日期 2015.09.14
申请人 Mediware Blood Management, LLC 发明人 Hannon Timothy
分类号 G06Q50/22;G06Q10/08 主分类号 G06Q50/22
代理机构 代理人
主权项 1. A method for measuring the utilization of blood products, comprising: using a computing device to receive a data file from a health care facility, the data file including blood product utilization data obtained from a group of patients of the health care facility having related diagnoses over a specified period of time; executing, by a processor of the computing device, a blood management software program to determine a patient population from the data file that received a blood product at the health care facility during the specified period of time, the patient population being identified from the group of patients having related diagnoses; generating a transfusion exposure score by calculating, by the processor, a geometric mean of a plurality of quantified blood products used on the patient population during the specified period of time at the health care facility; analyzing, by the processor, a plurality of transfusion exposure scores for a plurality of identified patient populations from different health care facilities to determine a benchmark transfusion exposure score, wherein the plurality of identified patient populations each consist of a group of patients having related diagnoses, the benchmark transfusion exposure score representing a target blood product utilization index score for patients having related diagnoses; and transforming, by the processor, a transfusion exposure score from one of the plurality of identified patient populations produced by the blood management software program and the benchmark transfusion exposure score produced by the blood management software program into a transfusion propensity index score, the transfusion propensity index score being representative of a clinical opportunity to improve the utilization of blood products at the health care facility for which the transfusion exposure score of the identified patient population was calculated.
地址 Lenexa KS US